US Regulation

Follow

PreCheck Program Expands Manufacturing

Reported by AI

The PreCheck program was launched to boost domestic pharmaceutical manufacturing in the US. It focuses on increasing production capacity and supply chain resilience. Regulatory developments also include blood-based tests for Alzheimer's detection.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline